Condition
Neonatal Sepsis, Early-Onset
Total Trials
6
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 6 trials
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 3 (1)
P 4 (1)
Trial Status
Unknown3
Not Yet Recruiting1
Recruiting1
Active Not Recruiting1
Clinical Trials (6)
Showing 6 of 6 trials
NCT07248761Phase 4Active Not Recruiting
Early Hydrocortisone Versus Regular Treatment in Shock in Extremely Preterm Neonates - an Open Randomized Controlled Trial
NCT07109856Not Yet Recruiting
The Peripheral(-Muscle) Oxygenation and Perfusion Score as a New Non-invasive Tool to Predict Elevations in C-reactive Protein Levels in Neonates
NCT07152106Recruiting
Amniotic Fluid & the Preterm Gut
NCT05763680UnknownPrimary
Molecular Culture for the Diagnosis of Neonatal Sepsis
NCT05589909UnknownPrimary
Performance of Interleukin-27 Cord Blood Level as A Biomarker Predicating Early Onset Neonatal Sepsis
NCT04041765Phase 3UnknownPrimary
IgM-Enriched Immunoglobulin for Neonatal Sepsis
Showing all 6 trials